
New data, which were published in the Feb. 1, 2005, issue of Clinical Infectious Diseases, demonstrated that Vicuron Pharmaceuticals' investigational antibiotic, dalbavancin, administered once per week, is more effective in treating catheter-related bloodstream infections than is twice-daily treatment with vancomycin.